Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC)

Anticancer Research

Volumn 19, Issue 2 C, 1999, Pages 1583-1587

  Brinkmann, Olaf A ^a   Bruns, F ^b   Prott, F J ^b   Hertle, L ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

Bone metastases; Immunotherapy; Radiotherapy; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; INTERLEUKIN 2;

ADULT; AGED; BONE METASTASIS; CANCER REGRESSION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CARCINOMA; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INTERFERON-ALPHA; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TIME FACTORS;

EID: 0032986337     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Hanash KA, Aquilina JW, Barrett DM, Blute ML, Cockett ATK, Corica FA, Hillman GG, Zbar B and Zhuang Z: Clinical research priorities in renal cell carcinoma. Cancer 80: 999-1001, 1997.
2. Elson PJ, Witte RS and Trump DL: Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 46: 7310-7313, 1988.
3. Swanson DA, Orovan WL, Johnson DE and Giaco G: Osseous metastases of renal cell carcinoma. Urology 18: 556, 1981.
4. Saitoh H: Distant metastasis of renal adenocarcinoma. Cancer 48: 1487, 1981.
5. Smith EC, Kursh ED, Makley J and Resnick MI: Treatment of osseous metastases secondary to renal cell carcinoma. J Urol 148: 784-787, 1992.
6. Fossa SD, Lien HH and Lindegaard M: Effect of recombinant Interferon alfa on bone metastases of renal cell carcinoma (Letter). New Engl J Med 324: 633-634, 1991.
7. Metzner, B, Siegmund R, Kirchner H, Atzpodien J and Illiger H J: Sprechen Knochenmetastasen auf eine Immuntherapie mit Interleukin-2 und Interferon-alpha -2b beim Nierenzellkarzinom an? Tumordiagn. u. Ther 12: 192-196, 1991.
8. Hofmockel G, Theiss M, Bussen D, Wirth, MP and Frohmuller H: Combination therapy with subcutaneously administered interleukin-2 and interferon- in advanced renal cell carcinoma. XIth Congress of the European Association of Urology July 1994, Abstract No. 604, Berlin, 1994.
9. Atzpodien J, Hanninen EL, Kirchner H, Bodenstein H, Pfreundschuh M, Rebmann U, Metzner B, Illiger H-J, Jakse G, Niesel T, Scholz H-J, Wilhelm S, Pielmeier T, Zakrzewski G, Blum G, Beier J, Muller G-W, Duesing St, Anton P, Allhof E, Jonas U and Poliwoda H: Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol 13: 497-501, 1995.
10. Walther MM, Alexander RB, Weiss GH, Venzon D, Berman A, Pass HI, Linehan WM and Rosenberg SA: Cytoreductive Surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology 42: 250-258, 1993.
11. Wolf JS, Aronson FR, Small EJ and Caroll PR: Nephrectomy for metastatic renal cell carcinoma: A component of systemic treatment regimens. J Surg Oncol 55: 7-13, 1994.
12. Gleave ME, Elhilali M, Fradet Y, Davis I, Venner P, Saad F, Klotz LH, Moore ML, Paton V, Bajamonde A and the Canadian Urologie Oncology 8 Group: Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. N Engl J Med 338: 1265-1271, 1988.
13. Harris DT: Hormonal therapy and chemotherapy of renal carcinoma. Semin Oncol 10: 422-430, 1983.
14. Motzer RJ, Vogelzang NJ: Chemotherapy for renal cell carcinoma. In: Principles and practice of genitourinary oncology (Raghavan D, Scher H.I, Leibel S.a:, Lange P. eds.). Philadelphia, Lippincott-Raven, 1997, pp. 885-896.
15. DeKernion JB and Belldegrun A: Treatment of metastatic renal cell carcinoma. in: Campbell's Urology (Walsh P.C, Retik A.B, Stamey T.A, Vaughan E.D, eds.) Philadelphia, W.B. Saunders company. 1992, 1079-1084.
16. Fossa SD, Kjolseth I and Lund G: Radiotherapy of metastases from renal cancer. Eur Urol 8: 340-342, 1982.
17. Jacobsen KD, Folleras G and Fossa SD: Metastases from renal carcinoma to the humerus or the shoulder girdle. Brit J Urol 43: 124-128, 1994.
18. Tschada R, Henkel Th, Rassweiler J and Alken P: Palliative Metastasenchirurgie versus konservative Therapie beim progredienten Nieren- zellkarzinom. Urologe A Supplement 1/94, V 11.8, p. 73, 1994.
19. Dybal J, Haas GP, Maughan RL, Sud S, Pontes JE, Hillmann GG: Synergy of radiation therapy and immunotherapy in murine renal cell carcinoma. J Urol 148: 1331-1337, 1992.
20. Younes E, Haas GP, Dezso B, Maughan RL, Montecillo E, Pontes JE, Hillmann GG: Radiation.induced effects on murine kidney tumor cells; role in the interaction of local irradiation and immunothearpy. J Urol 153: 2029-2033, 1995.